Sign up to see all 5.
Sign up to see all 5.
A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
B
BlackRock, Inc.
|
6.6M | 12.38% | +5.8M (+722.0%) | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding6.6M (Q2'26)
Change over 8 quarters+5.6M
Share of the company12.380%
|
||||||
|
BA
Balyasny Asset Management L.P.
|
3.6M | 6.83% | NEW | Q2 '26 | 0.0% | |
|
Shares held by quarter
Peak holding3.6M (Q2'26)
Change over 8 quarters+3.6M
Share of the company6.830%
|
||||||
28 more super investors behind a free account
See every manager holding Sagimet Biosciences Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FH
Federated Hermes Equity Funds
|
$14.8M | 2.1M | 3.92% | 0.52% | July 31, 2026 |
|
VT
Vanguard Index Funds
|
$14.4M | 1.9M | 3.50% | 0.00% | June 30, 2026 |
23 more funds behind a free account
See every fund holding Sagimet Biosciences Inc. and how much of the fund the position is.
Sign up freeLoading...